AEterna Zentaris Inc.

AEZS-T

TSE:AEZS

1.60
0.02 (1.27%)
Æterna Zentaris Inc. is a Quebec, Canada-based biopharmaceutical drug development company focused in oncology and endocrine therapy, currently investigating treatments for various unmet medical needs.
More at Wikipedia

Analysis and Opinions about AEZS-T

Signal
Opinion
Expert
SELL
SELL
January 26, 2012
Rather bad couple of days. Was down substantially, outside of a range. Consolidated. It broke down and is more likely to go down. $1.50 on the downside.
Show full opinionHide full opinion
Rather bad couple of days. Was down substantially, outside of a range. Consolidated. It broke down and is more likely to go down. $1.50 on the downside.
TOP PICK
TOP PICK
March 27, 2007
His stock filter picked stocks on a momentum basis and where money was flowing into them. The low it hit recently is a meaningful low. Likes the sector and feels it has been oversold. Do not let it violate the March low.
Show full opinionHide full opinion
His stock filter picked stocks on a momentum basis and where money was flowing into them. The low it hit recently is a meaningful low. Likes the sector and feels it has been oversold. Do not let it violate the March low.
BUY WEAKNESS
BUY WEAKNESS
September 7, 2004
Would like to get in at the $6 level. Cash flow positive.
Show full opinionHide full opinion
Would like to get in at the $6 level. Cash flow positive.
Showing 1 to 3 of 3 entries
  • «
  • 1
  • »